相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Antibodies to watch in 2017
Janice M. Reichert
MABS (2017)
High resolution separations of charge variants and disulfide isomers of monoclonal antibodies and antibody drug conjugates using ultra-high voltage capillary electrophoresis with high electric field strength
W. Hampton Henley et al.
JOURNAL OF CHROMATOGRAPHY A (2017)
Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates
Thomas Botzanowski et al.
MABS (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Real-Time Analysis on Drug-Antibody Ratio of Antibody-Drug Conjugates for Synthesis, Process Optimization, and Quality Control
Yubo Tang et al.
SCIENTIFIC REPORTS (2017)
Imaged capillary isoelectric focusing in native condition: A novel and successful example
Xin Zhang et al.
ANALYTICAL BIOCHEMISTRY (2017)
Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat, how shall we treat? A review of the literature
R. Stranzenbach et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Advances in antibody-drug conjugates: A new era of targeted cancer therapy
Samaresh Sau et al.
DRUG DISCOVERY TODAY (2017)
Inotuzumab Ozogamicin: First Global Approval
Yvette N. Lamb
DRUGS (2017)
Antibody-Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
John M. Lambert et al.
ADVANCES IN THERAPY (2017)
Quantitative Conjugated Payload Measurement Using Enzymatic Release of Antibody Drug Conjugate with Cleavable Linker
Brian Rago et al.
BIOCONJUGATE CHEMISTRY (2017)
Structural characterization of antibody drug conjugate by a combination of intact, middle-up and bottom-up techniques using sheathless capillary electrophoresis - Tandem mass spectrometry as nanoESI infusion platform and separation method
Nassur Said et al.
ANALYTICA CHIMICA ACTA (2016)
Characterization of Intact Antibody Drug Conjugate Variants Using Microfluidic Capillary Electrophoresis-Mass Spectrometry
Erin A. Redman et al.
ANALYTICAL CHEMISTRY (2016)
Antibody drug conjugates: lessons from 20 years of clinical experience
A. W. Tolcher
ANNALS OF ONCOLOGY (2016)
Cathepsin B Cleavage of vcMMAE-Based Antibody-Drug Conjugate Is Not Drug Location or Monoclonal Antibody Carrier Specific
Benson Gikanga et al.
BIOCONJUGATE CHEMISTRY (2016)
Characterization and Higher-Order Structure Assessment of an Interchain Cysteine-Based ADC: Impact of Drug Loading and Distribution on the Mechanism of Aggregation
Jianxin Guo et al.
BIOCONJUGATE CHEMISTRY (2016)
Antibody-drug conjugates-an emerging class of cancer treatment
Nikolaos Diamantis et al.
BRITISH JOURNAL OF CANCER (2016)
Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates
Alain Beck et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions
Morgan Sarrut et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
Investigation of low recovery in the free drug assay for antibody drug conjugates by size exclusion-reversed phase two dimensional-liquid chromatography
Yi Li et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
Multiple heart-cutting and comprehensive two-dimensional liquid chromatography hyphenated to mass spectrometry for the characterization of the antibody-drug conjugate ado-trastuzumab emtansine
Koen Sandra et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
A simple LC/MRM-MS-based method to quantify free linker-payload in antibody-drug conjugate preparations
Wesley Zmolek et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
Physical and Chemical Stability of Antibody Drug Conjugates: Current Status
Philip L. Ross et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
RP-HPLC DAR Characterization of Site-Specific Antibody Drug Conjugates Produced in a Cell-Free Expression System
Yiren Xu et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2016)
Antibody-drug conjugates: Current status and future perspectives
Remy Gebleux et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Early Patient Access to Medicines: Health Technology Assessment Bodies Need to Catch Up with New Marketing Authorization Methods
Lada Leyens et al.
PUBLIC HEALTH GENOMICS (2016)
Unconjugated payload quantification and DAR characterization of antibody-drug conjugates using high-resolution MS
Leanne Grafmuller et al.
BIOANALYSIS (2016)
Calculated conjugated payload from immunoassay and LC-MS intact protein analysis measurements of antibody-drug conjugate
Brian Rago et al.
BIOANALYSIS (2016)
Antibody-Drug Conjugates for Cancer Therapy
Adam C. Parslow et al.
BIOMEDICINES (2016)
Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry
Jessica R. McCombs et al.
AAPS JOURNAL (2015)
Tandem Native Mass-Spectrometry on Antibody-Drug Conjugates and Submillion Da Antibody-Antigen Protein Assemblies on an Orbitrap EMR Equipped with a High-Mass Quadrupole Mass Selector
Andrey Dyachenko et al.
ANALYTICAL CHEMISTRY (2015)
A size exclusion-reversed phase two dimensional-liquid chromatography methodology for stability and small molecule related species in antibody drug conjugates
Yi Li et al.
JOURNAL OF CHROMATOGRAPHY A (2015)
Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis
Marie-Claire Janin-Bussat et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2015)
Characterization of Cysteine-Linked Conjugation Profiles of Immunoglobulin G1 and Immunoglobulin G2 Antibody-Drug Conjugates
Brian Wiggins et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography
Robert E. Birdsall et al.
MABS (2015)
Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs
Christopher R. Behrens et al.
MOLECULAR PHARMACEUTICS (2015)
Maytansinoid-BODIPY Conjugates: Application to Microscale Determination of Drug Extinction Coefficients and for Quantification of Maytansinoid Analytes
Nathan Fishkin
MOLECULAR PHARMACEUTICS (2015)
Photoinduced Aggregation of a Model Antibody-Drug Conjugate
Gregory M. Cockrell et al.
MOLECULAR PHARMACEUTICS (2015)
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
Robert P. Lyon et al.
NATURE BIOTECHNOLOGY (2015)
Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loading
Pavel Strop et al.
NATURE BIOTECHNOLOGY (2015)
Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate
Julien Marcoux et al.
PROTEIN SCIENCE (2015)
Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC Efficacy
Magdalena Dorywalska et al.
PLOS ONE (2015)
Ado-trastuzumab Emtansine: A HER2-Positive Targeted Antibody-Drug Conjugate
Patricia A. Corrigan et al.
ANNALS OF PHARMACOTHERAPY (2014)
Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug Payload
Yilma T. Adem et al.
BIOCONJUGATE CHEMISTRY (2014)
Statistical Modeling of the Drug Load Distribution on Trastuzumab Emtansine (Kadcyla), a Lysine-Linked Antibody Drug Conjugate
Michael T. Kim et al.
BIOCONJUGATE CHEMISTRY (2014)
Mass Spectrometric Characterization of Transglutaminase Based Site-Specific Antibody-Drug Conjugates
Santiago E. Farias et al.
BIOCONJUGATE CHEMISTRY (2014)
Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling
Ruth Cohen et al.
CANCER RESEARCH (2014)
Gemtuzumab ozogamicin in acute myeloid leukemia revisited
Felicitas Thol et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Site-specific antibody drug conjugates for cancer therapy
Siler Panowski et al.
MABS (2014)
Methods for site-specific drug conjugation to antibodies
Christopher R. Behrens et al.
MABS (2014)
Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion
Elsa Wagner-Rousset et al.
MABS (2014)
Assessment of Physical Stability of an Antibody Drug Conjugate by Higher Order Structure Analysis: Impact of Thiol- Maleimide Chemistry
Jianxin Guo et al.
PHARMACEUTICAL RESEARCH (2014)
A general approach to site-specific antibody drug conjugates
Feng Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Monoclonal Antibodies in Cancer Therapy: Mechanisms, Successes and Limitations
A. Coulson et al.
WEST INDIAN MEDICAL JOURNAL (2014)
Development of a Native Nanoelectrospray Mass Spectrometry Method for Determination of the Drug-to-Antibody Ratio of Antibody-Drug Conjugates
Jia Chen et al.
ANALYTICAL CHEMISTRY (2013)
Conjugation Site Heterogeneity Causes Variable Electrostatic Properties in Fc Conjugates
Nicholas J. Boylan et al.
BIOCONJUGATE CHEMISTRY (2013)
Maturing antibody-drug conjugate pipeline hits 30
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2013)
Antibody-drug conjugates
Rachel S. Zolot et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
A Pictet-Spengler ligation for protein chemical modification
Paresh Agarwal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Protein Particulate Detection Issues in Biotherapeutics Development-Current Status
Tapan K. Das
AAPS PHARMSCITECH (2012)
Brentuximab vedotin in Hodgkin's lymphoma
Barbara Pro et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Ultra-high voltage capillary electrophoresis >300 kV: Recent advances in instrumentation and analyte detection
W. Hampton Henley et al.
JOURNAL OF CHROMATOGRAPHY A (2012)
Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates
Mauro Acchione et al.
MABS (2012)
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
Jun Y. Axup et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody-Drug Conjugates in Rats
C. Andrew Boswell et al.
BIOCONJUGATE CHEMISTRY (2011)
Identification of Amino Acid Residues Responsible for the Release of Free Drug from an Antibody-Drug Conjugate Utilizing Lysine-Succinimidyl Ester Chemistry
Hung-Wei Chih et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Fragmentation of monoclonal antibodies
Josef Vlasak et al.
MABS (2011)
Analytical methods for physicochemical characterization of antibody drug conjugates
Aditya Wakankar et al.
MABS (2011)
Site-Specific and Stoichiometric Modification of Antibodies by Bacterial Transglutaminase
Simone Jeger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Physicochemical Stability of the Antibody-Drug Conjugate Trastuzumab-DM1: Changes due to Modification and Conjugation Processes
Aditya A. Wakankar et al.
BIOCONJUGATE CHEMISTRY (2010)
Antibody-Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
Laurent Ducry et al.
BIOCONJUGATE CHEMISTRY (2010)
Charge variants in IgG1 Isolation, characterization, in vitro binding properties and pharmacokinetics in rats
Leslie A. Khawli et al.
MABS (2010)
Targeted cancer therapy: Conferring specificity to cytotoxic drugs
Ravi V. J. Chari
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Contribution of linker stability to the activities of anticancer immunoconjugates
Stephen C. Alley et al.
BIOCONJUGATE CHEMISTRY (2008)
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Jagath R. Junutula et al.
NATURE BIOTECHNOLOGY (2008)
Determination of pharmacokinetic values of calicheamicin-antibody conjugates in mice by plasmon resonance analysis of small (5 μl) blood samples
Erwin R. Boghaert et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma
Andrew G. Polson et al.
BLOOD (2007)
Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment
Charlotte F. McDonagh et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: Effects of linker technology on efficacy and toxicity
SO Doronina et al.
BIOCONJUGATE CHEMISTRY (2006)
Structural characterization of the maytansinoid -: monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry
LT Wang et al.
PROTEIN SCIENCE (2005)
Protein identification using 2D-LC-MS/MS
C Delahunty et al.
METHODS (2005)
Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry
AC Lazar et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate
KJ Hamblett et al.
CLINICAL CANCER RESEARCH (2004)
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
SO Doronina et al.
NATURE BIOTECHNOLOGY (2003)
Complex behavior in solution of homodimeric SecA
RL Woodbury et al.
PROTEIN SCIENCE (2002)
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells
VHJ van der Velden et al.
BLOOD (2001)